These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7883968)

  • 1. Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.
    Naredi P; Heath DD; Enns RE; Howell SB
    J Clin Invest; 1995 Mar; 95(3):1193-8. PubMed ID: 7883968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line.
    Naredi P; Heath DD; Enns RE; Howell SB
    Cancer Res; 1994 Dec; 54(24):6464-8. PubMed ID: 7987844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice.
    Lorico A; Bertola A; Baum C; Fodstad O; Rappa G
    Biochem Biophys Res Commun; 2002 Mar; 291(3):617-22. PubMed ID: 11855834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.
    Wasenius VM; Jekunen A; Monni O; Joensuu H; Aebi S; Howell SB; Knuutila S
    Genes Chromosomes Cancer; 1997 Apr; 18(4):286-91. PubMed ID: 9087568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
    Shen D; Pastan I; Gottesman MM
    Cancer Res; 1998 Jan; 58(2):268-75. PubMed ID: 9443404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic accumulation decreased in metallothionein null Cisplatin-resistant cell lines.
    Suzuki T; Ohata S; Togawa T; Himeno S; Tanabe S
    J Toxicol Sci; 2007 Aug; 32(3):321-8. PubMed ID: 17785947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of arsenite-resistant human epidermoid carcinoma KB cells.
    Tachiwada T; Chen ZS; Che XF; Matsumoto M; Haraguchi M; Gotanda T; Sumizawa T; Furukawa T; Nishiyama K; Seki N; Yamamoto M; Nakagawa M; Akiyama S
    Oncol Rep; 2007 Sep; 18(3):721-7. PubMed ID: 17671726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Andrews PA; Velury S; Mann SC; Howell SB
    Cancer Res; 1988 Jan; 48(1):68-73. PubMed ID: 3335000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-resistance to cisplatin in cells with acquired resistance to copper.
    Safaei R; Katano K; Samimi G; Naerdemann W; Stevenson JL; Rochdi M; Howell SB
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):239-46. PubMed ID: 14648017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe.
    Perego P; Jimenez G; Howell SB
    Mol Pharmacol; 1996 Nov; 50(5):1080-6. PubMed ID: 8913338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
    Zhou Y; Chen H; Yang Q
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):680-3. PubMed ID: 9275551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
    Jekunen A; Vick J; Sanga R; Chan TC; Howell SB
    Cancer Res; 1992 Jul; 52(13):3566-71. PubMed ID: 1617625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines].
    Yang X; Zheng F; Xing H; Gao Q; Wang W; Lu Y; Wang S; Ma D
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):544-7. PubMed ID: 12667321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro.
    Jekunen AP; Shalinsky DR; Hom DK; Albright KD; Heath D; Howell SB
    Biochem Pharmacol; 1993 May; 45(10):2079-85. PubMed ID: 8512589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.